Logo Mark Trademark Information

Trademark by SAREPTA THERAPEUTICS, INC.

chemical compounds and additives for use in pharmaceutical research or the manufacture of pharmaceuticals

pharmaceuticals and pharmaceutical products for treating muscular dystrophy, (( infectious diseases and viruses that respond to ribonucleic acid (RNA)-based therapies; )) pharmaceuticals comprising drugs based on Phosphorodiamidate Morpholino Oligomers technology platform, and drugs that modulate RNA expression

medical and scientific research services, namely, medical research; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (001)
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
First Use Anywhere:: 7/12/2012
First Use In Commerce: 10/15/2014
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: 7/12/2012
First Use In Commerce: 10/15/2014
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 7/12/2012
First Use In Commerce: 10/15/2014
General Information
Word mark: (NO WORD)
Status/Status Date:
STATEMENT OF CONTINUED USE ACCEPTED
6/22/2021
Serial Number: 86121578
Filing Date: 11/18/2013
Registration Number: 4657552
Registration Date: 12/16/2014
Goods and Services: chemical compounds and additives for use in pharmaceutical research or the manufacture of pharmaceuticals
Mark Description: The mark consists of an abstract representation of the DNA double helix structure.
Type Of Mark: Service Mark
Published For Opposition Date: 2/18/2014
Last Applicant/Owner:
SAREPTA THERAPEUTICS, INC.
********
********
***** ****
Mark Drawing Code: Drawing/Design (No Words)
Design Search:
Helixes (Geometric figures and solids - Coding and searching guide) see more design...
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
STATEMENT OF CONTINUED USE ACCEPTED
6/22/2021
Correspondent Search:
Paul C. Llewellyn is a correspondent of the Logo trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on